ライフサイエンスコーパス: mononuclear cell

1 hometric analysis (number of neutrophils and mononuclear cells).

2 orphometric analysis (number neutrophils and mononuclear cells).

3 primary AML patient blasts but not in normal mononuclear cells.

4 of in vitro-cultured human peripheral blood mononuclear cells.

5 1 infected T cells by human peripheral blood mononuclear cells.

6 T cells isolated from human peripheral blood mononuclear cells.

7 in 42 vaccinees using fresh peripheral blood mononuclear cells.

8 om a viral antigen in human peripheral blood mononuclear cells.

9 or AG (p < 0.001) in total peripheral blood mononuclear cells.

10 ation, including recruitment of inflammatory mononuclear cells.

11 interleukin-1beta in human peripheral blood mononuclear cells.

12 od mononuclear cells and neonatal cord blood mononuclear cells.

13 termined in neutrophils and peripheral blood mononuclear cells.

14 lls such as HEK293 or human peripheral blood mononuclear cells.

15 epithelial cells, and human peripheral blood mononuclear cells.

16 antibody binding to porcine peripheral blood mononuclear cells.

17 or inflammation are neutrophils, followed by mononuclear cells.

18 in the liver, both in hepatocytes and liver mononuclear cells.

19 F-alpha production by human peripheral blood mononuclear cells.

20 ses of HIV-1 in circulating peripheral blood mononuclear cells.

21 cally in the skin lesions and in circulating mononuclear cells.

22 to suppress activated human peripheral blood mononuclear cells.

23 tions of 12,727 genes derived from SCD blood mononuclear cells.

24 lones could be derived from peripheral blood mononuclear cells.

25 ignificant decrease in islet infiltration of mononuclear cells.

26 s, primary macrophages, and peripheral blood mononuclear cells.

27 tion fraction was similar in the bone marrow mononuclear cells (48.7%) and placebo groups (51.6%) wit

28 vels of proinflammatory mediators leading to mononuclear cell activation and recruitment could underl

29 Plaque reduction correlated with mononuclear cell activation.

30 levation myocardial infarctions, bone marrow mononuclear cells administration did not improve recover

31 : Intracoronary infusion of bone marrow (BM) mononuclear cells after acute myocardial infarction (AMI

32 were associated with higher peripheral blood mononuclear cell and gut integrated HIV DNA levels.

33 pression was observed in primary human blood mononuclear cells and a subset of leukemia cell lines.

34 t was evaluated using human peripheral blood mononuclear cells and by testing for antigen presentatio

35 g virulent mycobacteria, primary human blood mononuclear cells and collagen-alginate matrix to dissec

36 vani and also reemphasize that (i) recruited mononuclear cells and granulomas are not required to con

37 nted peptides in synovia or peripheral blood mononuclear cells and identified 2 autoantigens, N-acety

38 ammatory responses in human peripheral blood mononuclear cells and in monocolonized mice.

39 emory phenotype, present in peripheral blood mononuclear cells and intestinal tissue, and had a diver

40 We collected samples of peripheral blood mononuclear cells and intestinal tissues from healthy in

41 In an analysis of peripheral blood mononuclear cells and intestinal tissues from patients w

42 -blind MeV were detected in peripheral blood mononuclear cells and lymph node homogenates, but only t

43 Patient's and father's peripheral blood mononuclear cells and macrophages demonstrated impaired

44 mononuclear cells may outperform bone marrow-mononuclear cells and mesenchymal stem cells.

45 of CD300 receptors on adult peripheral blood mononuclear cells and neonatal cord blood mononuclear ce

46 adelta T-cell subset within peripheral blood mononuclear cells and other annexin A2-specific Vdelta2(

47 By sorting human peripheral blood mononuclear cells and performing quantitative RT-PCR, GI

48 platform 'omics analysis of peripheral blood mononuclear cells and plasma from EVD patients.

49 histone (H3) acetylation in peripheral blood mononuclear cells and reduced interleukin 6 (P = .028) a

50 Peripheral blood mononuclear cells and sera were obtained from individual

51 Cryopreserved peripheral blood mononuclear cells and serum samples collected at baselin

52 Lamina propria mononuclear cells and T cells were isolated and analyzed

53 al pathways was examined in peripheral blood mononuclear cells and transfected HEK293T cells through

54 ncers, does not bind normal peripheral blood mononuclear cells, and can activate immune effector func

55 g microglia-like cells from peripheral blood mononuclear cells, and combining them with NPCs and neur

56 disorganized accumulation of lymphocytes and mononuclear cells, and extensive pulmonary immunopatholo

57 ells with cynomolgus monkey peripheral blood mononuclear cells, and had minimal complement-dependent

58 CD34+ cells, in 'inflammatory disease' in MF mononuclear cells, and in 'immunological diseases' in MF

59 ix different cytokines in whole blood, blood mononuclear cells, and macrophages.

60 ritic cells [moDCs], PBMCs [peripheral blood mononuclear cells] and epithelial and iNKT-hybridoma cel

61 d ATL cells, but not normal peripheral blood mononuclear cells, are highly sensitive to AZD1208, and

62 m malaria (n = 129) had significantly higher mononuclear cell arginase 1 mRNA, protein, and enzyme ac

63 etic cell mixture and human peripheral blood mononuclear cells as model systems.

64 xpression data derived from peripheral blood mononuclear cells as well as 16S ribosomal RNA sequencin

65 tibodies were detected in a peripheral blood mononuclear cell assay, and moderate antibody-dependent,

66 responses) from stimulated peripheral blood mononuclear cells at age 3 years.

67 IV-1 activity in TZM-bl and peripheral blood mononuclear cells at low nanomolar concentrations and di

68 ulticolor flow cytometry of peripheral blood mononuclear cells before transplantation and serially po

69 was predominantly detected in isolated brain mononuclear cells, blood monocytes, and peritoneal macro

70 Bone marrow mononuclear cell (BM-MNC) therapy in ST-elevation acute

71 y infusion of autologous bone marrow-derived mononuclear cells (BMCs) are heterogeneous, which may be

72 Considering bone marrow mononuclear cells (BMMC) are easily obtained and readily

73 BP case/control: 45/50) and peripheral blood mononuclear cells (BP case/control: 193/593).

74 decreased DNMT1 protein in peripheral blood mononuclear cells by >75% and repetitive element CpG met

75 e syncytiotrophoblast and placental maternal mononuclear cells by immunohistochemical analysis, and n

76 tion of tumor-infiltrating polymorphonuclear mononuclear cells caused by Cxcl-1 released from cancer-

77 ively expanding two key types of bone marrow mononuclear cells: CD90+ mesenchymal stem cells and CD45

78 Compared with unselected peripheral blood mononuclear cells, CMV-CTLs induced significantly less s

79 ressive effect of hBMSC and peripheral blood mononuclear cell co-cultured exosomes for improving isle

80 xogenous recombinant porcine IL-10 + IL-6 to mononuclear cells cocultured with LGG significantly enha

81 Peripheral blood mononuclear cells collected during episodes of BK viral

82 rticosteroid sensitivity of peripheral blood mononuclear cells collected from patients with COPD, smo

83 s of IFN-gamma and IL-17 in peripheral blood mononuclear cells compared with healthy phylotypes.

84 ADAM-10 and ADAM-17 in old peripheral blood mononuclear cells compared with those of young subjects

85 ral IFN-stimulated genes in peripheral blood mononuclear cells, compared to pigs treated with Ad5-Blu

86 es LY6E expression in human peripheral blood mononuclear cells, concomitant with increased production

87 All recurrent mutations identified in mononuclear cells could be tracked back to the phenotypi

88 4H promoter polymorphism correlated with CSF mononuclear cell count but not with mortality (P = .915)

89 n to recurrent wheezing and peripheral blood mononuclear cell cytokine responses at age 3 years.

90 Nonetheless, peripheral blood mononuclear cell DEGs associated with major histocompati

91 After saline challenge, BAL mononuclear cells demonstrated little APC function.

92 In addition, siRNA delivery to mononuclear cells derived from AML patients led to signi

93 Peripheral blood mononuclear cell-derived DEGs were more psoriasis specif

94 Cord blood mononuclear cell-derived IL-1beta levels were measured b

95 AP/CDKN2A-CDKN2B loci in 77 peripheral blood mononuclear cell DNA samples from patients with SS did n

96 measured longitudinally in peripheral blood mononuclear cells during human aging, in tissues during

97 rimary AML cells with donor peripheral blood mononuclear cells elicited a cell contact-dependent expa

98 derived from unfractionated peripheral blood mononuclear cells, ex vivo-isolated CD4+ T cells, and su

99 cellular IL-10 secreted in peripheral blood mononuclear cells exposed to RhCMV antigens and shedding

100 e enumerated by flow cytometry as CD45(med+) mononuclear cells expressing CD34 and subsets coexpressi

101 erated by flow cytometry as CD45med(+) blood mononuclear cells expressing CD34, CD133, vascular endot

102 reening for recurrently mutated genes in the mononuclear cell fraction revealed mutations in SF3B1 in

103 d breaks were determined in peripheral blood mononuclear cells from 13 pSS patients, using comet assa

104 od and urine, and %PTHMs in peripheral blood mononuclear cells from 317 participants enrolled in the

105 iRNA expression profiles in peripheral blood mononuclear cells from 35 transplant recipients with and

106 chip to survey DNA methylation in cord blood mononuclear cells from 36 children (18 nonasthmatic and

107 Mononuclear cells from 56 blood donors and 10 livers tha

108 We isolated peripheral blood mononuclear cells from 65 patients with CD and 45 health

109 ranscriptional profiling of peripheral blood mononuclear cells from AA or white, normotensive or hype

110 Analysis of peripheral blood mononuclear cells from age-matched healthy controls with

111 Analysis of peripheral blood mononuclear cells from an affected subject showed reduce

112 d 56% of tax sequences from peripheral blood mononuclear cells from animals 12141 and 12752, respecti

113 Peripheral blood mononuclear cells from cases had shorter telomeres but i

114 tential was evaluated using peripheral blood mononuclear cells from celiac patients after receiving a

115 ay data were generated from peripheral blood mononuclear cells from Chinese children with acute infec

116 Peripheral blood mononuclear cells from chronic lymphocytic leukemia (CLL

117 nses previously observed in peripheral blood mononuclear cells from donors from regions where DENV is

118 n A2-transgenic mice and on peripheral blood mononuclear cells from ESO-vaccinated melanoma patients.

119 cells were significantly higher in recovered mononuclear cells from gingival tissues of the CD1d(hi)

120 Peripheral blood mononuclear cells from healthy controls and viremic KTR

121 We stimulated peripheral blood mononuclear cells from healthy donors and observed that

122 Peripheral blood mononuclear cells from healthy donors were cultured with

123 Peripheral blood mononuclear cells from healthy subjects homozygous for t

124 Peripheral blood mononuclear cells from healthy volunteers were cultured

125 ma and IL-17A production in peripheral blood mononuclear cells from HIV-infected ART-treated individu

126 Peripheral blood mononuclear cells from HIV-infected women on antiretrovi

127 D4(+)T cells are present in peripheral blood mononuclear cells from HLA-DRB1*11 and HLA-DRB1*03-posit

128 Peripheral blood mononuclear cells from immune donors were transfected wi

129 Mononuclear cells from liver and blood were studied by f

130 Peripheral blood mononuclear cells from male children with ASD (n = 50) a

131 ishmania antigen-stimulated peripheral blood mononuclear cells from patients infected with L. brazili

132 We collected peripheral blood mononuclear cells from patients with ALF and controls fr

133 R activity was increased in peripheral blood mononuclear cells from patients with COPD, and treatment

134 In peripheral blood mononuclear cells from patients with SS, codeletion with

135 Peripheral blood mononuclear cells from SLA identical wild type (WT), alp

136 ctedly, pathogen-stimulated peripheral blood mononuclear cells from subjects homozygous for the high-

137 cell lines (BLCLs), but not peripheral blood mononuclear cells, from which they were derived.

138 s, most of which used autologous bone marrow mononuclear cells, have found only a modest benefit in p

139 SAC resulted in a 12-fold increase in mononuclear cells having the morphologic appearance of b

140 capitulated in vitro in mouse lamina propria mononuclear cells, human colonic epithelial cells, and h

141 Applying CARD-SGS to blood mononuclear cells in six samples from four HIV-infected

142 tion of interferon-gamma by peripheral blood mononuclear cells in the anakinra arm was decreased, and

143 tes, CD86 was still expressed by part of the mononuclear cells in the explant.Isolated graft cells we

144 tion of sialidases to human peripheral blood mononuclear cells induces accumulation of extracellular

145 ch skin ulcer development is associated with mononuclear cell infiltrate and high levels of inflammat

146 fected kidney showed interstitial nephritis, mononuclear cell infiltrates, and reduced size of glomer

147 1 AIH, including marked and persistent liver mononuclear cell infiltration, hepatic fibrosis, hyperga

148 , eluted from human and pig peripheral blood mononuclear cells, interacted across species and bound s

149 tetramers and added them to peripheral blood mononuclear cells isolated from 143 HLA-DQ2.5(+) subject

150 Peripheral blood mononuclear cells isolated from CHIKV-infected patients

151 GS-9620, activated HIV from peripheral blood mononuclear cells isolated from HIV-infected individuals

152 integrins and of chemotaxis is defective in mononuclear cells isolated from patients with CF.

153 m at single-cell resolution from bone marrow mononuclear cells isolated from transplant patients.

154 ranscriptional profiling of peripheral blood mononuclear cells isolated within the first few hours to

155 Mainly the transcriptome of lamina propria mononuclear cells (LPMC) was affected by TSO treatment,

156 ial infusion, and mobilized peripheral blood mononuclear cells may outperform bone marrow-mononuclear

157 Ly6C(hi) CD11b(+) CCR2(+) activated myeloid mononuclear cells (MMCs) and the levels of proinflammato

158 of IL-5 and IL-13 from splenocytes and liver mononuclear cells (MNCs) of infected mice.

159 r, exposure of macrophages, peripheral blood mononuclear cells, monocyte-derived dendritic cells, and

160 by transferring allogeneic peripheral blood mononuclear cells more effectively than polyclonal Tregs

161 ive oxygen species (ROS) in stimulated human mononuclear cells more efficiently than Trolox.

162 97 spot-forming units/10(6) peripheral blood mononuclear cells), most frequently targeting ORF2.

163 d primary human peripheral blood and hepatic mononuclear cells, mouse MAIT hybridoma lines, HLA-DR4-t

164 ionated bone marrow (BM) or peripheral blood mononuclear cells (n = 10) resulted in robust engraftmen

165 curred in liver samples and peripheral blood mononuclear cells of patients with ALD/alcoholic hepatit

166 utive IL-1beta release from peripheral blood mononuclear cells of patients with FMF or HIDS was atten

167 Ralpha is down-modulated in peripheral blood mononuclear cells of patients with lung cancer, particul

168 and A20 were diminished in peripheral blood mononuclear cells of sepsis patients, whereas p38 mitoge

169 eprae antigens in the PBMC (peripheral blood mononuclear cells) of 69 healthy people.

170 ry of ICOVIR-15K-cBiTE with peripheral blood mononuclear cells or T cells enhanced the antitumor effi

171 Peripheral blood mononuclear cells or whole blood were collected at basel

172 70 spot-forming cells/10(6) peripheral blood mononuclear cells; P = .06) in vaccinees versus placebo

173 ned off ERT with normalized peripheral blood mononuclear cell (PBMC) ADA activity, improved lymphocyt

174 NV-3 intrahost diversity in peripheral blood mononuclear cell (PBMC) and plasma samples from 77 dengu

175 We have taken the standard peripheral blood mononuclear cell (PBMC) based viral outgrowth methodolog

176 e secretion of cytokines in Peripheral blood mononuclear cell (PBMC) culture from CM allergic patient

177 blood concentration of the peripheral blood mononuclear cell (PBMC) fraction were efficiently separa

178 We investigated peripheral blood mononuclear cell (PBMC) microRNA and protein-coding gene

179 o viral rebound or reducing peripheral blood mononuclear cell (PBMC) or lymph node proviral DNA level

180 ession of parasite-specific peripheral blood mononuclear cell (PBMC) proliferation was evident, while

181 o co-culture model of human peripheral blood mononuclear cell (PBMC) responses to Escherichia coli wa

182 We investigated 607 peripheral blood mononuclear cell (PBMC) samples from 107 CMV-seropositiv

183 l efflux capacity (CEC) and peripheral blood mononuclear cell (PBMC) transcriptomics in patients rece

184 to the injured pancreas or peripheral blood mononuclear cell (PBMC), which can target the NF-kappaB1

185 ral HIV-DNA copy numbers in peripheral blood mononuclear cells (PBMC) (Rho = 0.4011; P = 0.0027).

186 significantly increased in peripheral blood mononuclear cells (PBMC) along with the number of copies

187 ammary epithelial and human peripheral blood mononuclear cells (PBMC) by MTT assay.

188 ac(-/-) (NSG) mice received peripheral blood mononuclear cells (PBMC) derived from allergic patients

189 ivo cultures of naive human peripheral blood mononuclear cells (PBMC) exposed to P. falciprum infecte

190 Peripheral blood mononuclear cells (PBMC) from 20 HDM-allergic individual

191 Mycobacterial growth in peripheral blood mononuclear cells (PBMC) from both humans and macaques w

192 xpected, MDSC isolated from peripheral blood mononuclear cells (PBMC) from cancer patients produced h

193 revent ex vivo infection of peripheral blood mononuclear cells (PBMC) from SM or vervet AGM.

194 s coadministered with human peripheral blood mononuclear cells (PBMC) in NOD/SCID mice harboring xeno

195 ant protein MCP-1, which in peripheral blood mononuclear cells (PBMC) stimulated the production of VE

196 nscriptional differences in peripheral blood mononuclear cells (PBMC), and in purified cell subsets f

197 observable cytotoxicity in peripheral blood mononuclear cells (PBMC), good cell-permeability, and me

198 within whole blood (WB) and peripheral blood mononuclear cells (PBMC).

199 ely 0.1% of the circulating peripheral blood mononuclear cells (PBMC).

200 anges in gene expression in peripheral blood mononuclear cells (PBMC).

201 nally for up to 14 years in peripheral blood mononuclear cells (PBMCs) among 61 perinatally HIV-1-inf

202 pecific T-cell responses in peripheral blood mononuclear cells (PBMCs) and breast milk cells (BMCs) i

203 Here we found that human peripheral blood mononuclear cells (PBMCs) and cell lines expressing the

204 M-specific proliferation of peripheral blood mononuclear cells (PBMCs) and interferon gamma (IFN-gamm

205 type 4 (CCR5 and CXCR4) on peripheral blood mononuclear cells (PBMCs) and macrophages ex vivo as a p

206 sed ex vivo stimulations of peripheral blood mononuclear cells (PBMCs) and monocytes obtained during

207 The proportion of peripheral blood mononuclear cells (PBMCs) and of CSF white blood cells (

208 Peripheral blood mononuclear cells (PBMCs) and plasma were collected at a

209 RNA and nested PCR on bulk peripheral blood mononuclear cells (PBMCs) and sigmoid biopsies after ser

210 eshly isolated B cells from peripheral blood mononuclear cells (PBMCs) and that activation can be inh

211 ells were sorted from human peripheral blood mononuclear cells (PBMCs) by intracellular staining and

212 ells were sorted from human peripheral blood mononuclear cells (PBMCs) by intracellular staining and

213 We prospectively collected peripheral blood mononuclear cells (PBMCs) by leukapheresis from a 55-yea

214 ofiles using microarrays on peripheral blood mononuclear cells (PBMCs) from 18 early-onset SZ cases a

215 ce of the Warburg effect in peripheral blood mononuclear cells (PBMCs) from 30 premutation carriers w

216 ristics of the assays using peripheral blood mononuclear cells (PBMCs) from 5 viremic patients and 20

217 together with AF DENV-2 on peripheral blood mononuclear cells (PBMCs) from children in Thailand with

218 Peripheral blood mononuclear cells (PBMCs) from donors positive for IgE t

219 In this study, we screened peripheral blood mononuclear cells (PBMCs) from donors vaccinated with a

220 nist GS-9620 induced HIV in peripheral blood mononuclear cells (PBMCs) from HIV-infected individuals

221 Peripheral blood mononuclear cells (PBMCs) from infection-prone (IP) and

222 Further, in peripheral blood mononuclear cells (PBMCs) from patients with cutaneous l

223 n direct IFNalpha exposure, peripheral blood mononuclear cells (PBMCs) from patients with SVR upregul

224 Ex vivo-isolated peripheral blood mononuclear cells (PBMCs) from peanut-allergic (PA) and

225 m sites of inflammation and peripheral blood mononuclear cells (PBMCs) from treatment-naive subjects

226 e co-cultured in vitro with peripheral blood mononuclear cells (PBMCs) in the presence of the glycoly

227 analyse ZIKV infectivity of peripheral blood mononuclear cells (PBMCs) in vitro and from Nicaraguan Z

228 Peripheral blood mononuclear cells (PBMCs) obtained from allergic individ

229 to quantitate mutations in peripheral blood mononuclear cells (PBMCs) of 686 women with primary OC (

230 a novel strategy of pooling peripheral blood mononuclear cells (PBMCs) of six select HIV-1 chronicall

231 at baseline and 3 hours in peripheral blood mononuclear cells (PBMCs) using the Infinium Methylation

232 Peripheral blood mononuclear cells (PBMCs) were also isolated.

233 ion (CD3, CD4 and CXCR3) in peripheral blood mononuclear cells (PBMCs) were assayed.

234 Human peripheral blood mononuclear cells (PBMCs) were isolated from blood of he

235 ls of integrated HIV DNA in peripheral blood mononuclear cells (PBMCs) were longitudinally monitored

236 , and very large numbers of peripheral blood mononuclear cells (PBMCs) were obtained longitudinally f

237 isolated mRNAs from feline peripheral blood mononuclear cells (PBMCs), and used available immunoglob

238 nd the recruitment of human peripheral blood mononuclear cells (PBMCs).

239 cytotoxic T cells (CTLs) in peripheral blood mononuclear cells (PBMCs).

240 me was HO-1 upregulation in peripheral blood mononuclear cells (PBMCs).

241 mouse macrophages and human peripheral blood mononuclear cells (PBMCs).

242 quantitation of HIV RNA in peripheral blood mononuclear cells (PBMCs; n = 72), seminal plasma (n = 2

243 were further validated with peripheral blood mononuclear cells (PBMNCs) isolated from patients and he

244 proliferated in response to peripheral blood mononuclear cells previously exposed to CMV-derived (but

245 sponses were examined using peripheral blood mononuclear cells pulsed with 6 HER2-derived class II-pr

246 lymphoma 6 (BCL6) in human peripheral blood mononuclear cells purified from active cGVHD patients.

247 yzed co-cultures with human peripheral blood mononuclear cells, purified monocytes, T cells and monoc

248 ical complement may be therapeutic to dampen mononuclear cell recruitment and endothelial activation

249 XCL16, CCL2, and CCL5-for their roles in (i) mononuclear cell recruitment and granuloma assembly and

250 nd that a subset of peripheral blood myeloid mononuclear cells represent a key effector cell populati

251 ve transfer of DJ-1(-/-) bone marrow-derived mononuclear cells rescued wild-type mice from cecal liga

252 By contrast, the patient's peripheral blood mononuclear cells responded normally to all TLR1/2, TLR2

253 Inhibiting CDK9 activity in peripheral blood mononuclear cells resulted in the loss of Mcl-1 expressi

254 ividuals must have had a peripheral blood or mononuclear cell sample collected before the diagnosis o

255 We investigated 604 peripheral blood mononuclear cell samples from 108 CMV- and EBV-seroposit

256 CT and had archived pre-HCT peripheral blood mononuclear cell samples.

257 Peripheral blood mononuclear cells samples were stained with a 38-marker

258 Following SAC, BAL mononuclear cells showed function equal to pDC from bloo

259 Flow cytometric analysis of CNS-infiltrating mononuclear cells showed that CD4(+) T cells and monocyt

260 prospectively collected 177 peripheral blood mononuclear cell specimens from 39 lung transplant recip

261 tably, addition of recombinant SP-D to naive mononuclear cells stimulated IFN-gamma release in vitro.

262 Human mononuclear cells stimulated with lysates from putative

263 onstrate unambiguously that peripheral blood mononuclear cell subpopulations display dramatically dif

264 Osteoclasts begin as mononuclear cells that fuse to form multinuclear cells a

265 ost range in primary rhesus peripheral blood mononuclear cells that included CCR5(+) CD8(+) T cells.

266 LB/c mice induced a time-dependent influx of mononuclear cells that were primarily macrophages of ant

267 immunohistochemistry, on tumor infiltrating mononuclear cells (TIMCs) and tumor cells was scored fro

268 We profiled 68k peripheral blood mononuclear cells to demonstrate the system's ability to

269 and an enhanced IL-10 response of cord blood mononuclear cells to dexamethasone treatment in culture

270 inflammatory cytokine response of cord blood mononuclear cells to innate and mitogenic stimuli (P = .

271 l inflammation and enhanced peripheral blood mononuclear cells trafficking to the arterial wall compa

272 ature derived from grouping peripheral blood mononuclear cell transcriptomes distinguished 2 patient

273 9.0% of pretransplantation peripheral blood mononuclear cell Treg cell were donor-reactive, compared

274 tory effects on the activation of peripheral mononuclear cells using in vitro models of transplantati

275 lled trial comparing 150 million bone marrow mononuclear cells versus placebo in 120 patients with an

276 ecretion of these miRNAs by peripheral blood mononuclear cells was also significantly impaired in RRM

277 histochemistry, the number of CXCR3-positive mononuclear cells was higher in skin and intestinal lesi

278 issues were collected; hepatocytes and liver mononuclear cells were analyzed by histology, immunoblot

279 Plasma and peripheral blood mononuclear cells were collected at multiple time points

280 Peripheral blood mononuclear cells were cultured unstimulated (U), with p

281 Pancreatic acini and peripheral blood mononuclear cells were exposed to FAs or FAEEs in vitro.

282 Human primary TEC and peripheral blood mononuclear cells were infected with BKV Dunlop strain o

283 Mononuclear cells were isolated and analyzed by flow cyt

284 mplement, and cryoglobulin; peripheral blood mononuclear cells were isolated for flow cytometry analy

285 Peripheral blood mononuclear cells were isolated from acute respiratory d

286 Mononuclear cells were isolated from blood before treatm

287 lyze the level of DNA DSBs, peripheral blood mononuclear cells were isolated from blood samples drawn

288 analyses were performed, and, when feasible, mononuclear cells were isolated from fresh, dissociated

289 Mononuclear cells were isolated from spleen and liver fo

290 Peripheral blood mononuclear cells were obtained at week 26 from all 25 p

291 Peripheral blood mononuclear cells were obtained from children aged 4-18

292 d mRNA expression levels in peripheral blood mononuclear cells were quantified via microarray gene ch

293 Peripheral blood mononuclear cells were stained with monoclonal anti-CD4

294 Peripheral blood mononuclear cells were stimulated for 12 days with pepti

295 Separately, matched peripheral blood mononuclear cells were stimulated in vitro with heat-kil

296 -12 by monocytes from human peripheral blood mononuclear cells, while its isogenic nonmotile mutant l

297 Finally, treatment of human mononuclear cells with a monoclonal anti-TLR10 Ab suppre

298 was assessed by stimulating peripheral blood mononuclear cells with CMV pp65 or IE-1 peptide pools an

299 that pretreatment of human peripheral blood mononuclear cells with HMBA led to a markedly increased

300 In vitro treatment of mononuclear cells with these probiotics demonstrated tha